Last updated on May 2019

ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Na ve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)


Brief description of study

The purpose of this study is to assess ALXN1210 compared to eculizumab in adult patients with PNH who have not previously used a complement inhibitor.

Clinical Study Identifier: NCT02946463

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.